NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/16/2025
Back to search
Official data from USPTO
NK-92
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
09/10/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
11/29/2017
Registration date
07/10/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2025
Last transaction
09/10/2025
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
First use anywhere
1994-00-00
First use in commerce
1994-00-00
Drawing code
4
Owner type
03
Owner location
SAN DIEGO, CA
Examiner
BUSH, KAREN
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
IMMUNITYBIO, INC.
NantKwest, Inc.
Representatives
Alicia M. Passerin LEECH TISHMAN FUSCALDO & LAMPL
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cells for scientificlaboratorymedicalclinicaltherapeuticdiagnostic research; cell-derived preparationsnatural killer cell-derived preparationsfor scientificlaboratorymedicalclinicaltherapeuticdiagnostic research; Kits comprised of cellsreagents and related instructionsfor clinicalmedicinaltherapeutic research purposes; kits comprised of cell-derived preparationsnatural killer cell-derived preparationsreagents and related instructionsfor clinicalmedicinaltherapeutic research purposes
Class 5
Cells for clinicalmedicalveterinarytherapeutic purposes; cell-derived preparationsnatural killer cell-derived preparationsfor clinicalmedicalveterinarytherapeutic purposes; therapeutic products derived from cellsnatural killer cellsfor clinicalmedicalveterinarytherapeutic purposes; therapeutic products derived from cell-derived preparationsnatural killer cell-derived preparationsfor clinicalmedicalveterinarytherapeutic purposes; Kits comprised of cellsreagents and related instructionsfor clinicalmedicinalveterinarytherapeutic purposes; kits comprised of cell-derived preparationsnatural killer cell-derived preparationsreagents and related instructionsfor clinicalmedicinalveterinarytherapeutic purposes
Class 42
Research in the field of cancer; product development in the fields of sciencemedicinepharmaceuticalsveterinary medicinetherapeutics and research related thereto
Publications
History of USPTO decisions and trademark events.
16 publications found
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/16/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/15/2025
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
11/20/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/20/2024
E815
TEAS SECTION 8 & 15 RECEIVED
06/06/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/10/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/10/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/24/2018
PUBO
PUBLISHED FOR OPPOSITION
04/24/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/04/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/20/2018
DOCK
ASSIGNED TO EXAMINER
03/13/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2017
NWAP
NEW APPLICATION ENTERED
12/02/2017
Continuous trademark protection
Get notified about every new filing that threatens NK-92 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.